Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Oderda

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
European Radiology|March 15, 2022
mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imagingMarco Gatti, Riccardo Faletti, Francesco Gentile, et al.
Oncotarget|September 10, 2016
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-upRossana Critelli, Francesca Fasanelli, Marco Oderda, et al.
Frontiers in Oncology|February 16, 2026
PSMA-guided management of recurrent post-prostatectomy patients: a sub-analysis of a prospective single-center studyGiuseppe Carlo Iorio, Cristiano Grossi, Valeria Chiofalo, et al.
Frontiers in Oncology|April 25, 2022
Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective StudyJunlong Zhuang, Yansheng Kan, Yuwen Wang, et al.
BJU International|May 27, 2020
Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 casesGiancarlo Marra, Junlong Zhuang, Mattia Beltrami, et al.
The Prostate|May 29, 2025
Role of Cell-Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2-ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active SurveillanceMarco Oderda, Giulia Orlando, Giorgio Calleris, et al.
European Urology Focus|May 17, 2020
Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?Giancarlo Marra, Giorgio Calleris, Paolo Alessio, et al.
Urologia|May 8, 2023
The impact of single-use digital flexible cystoscope for double J removal on hospital costs and work organization: A multicentric evaluationMarco Oderda, Antonio Amato, Jean de la Rosette, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Comparative Performance of <sup>68</sup>Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical ProstatectomyGuido Rovera, Serena Grimaldi, Marco Oderda, et al.
The Journal of Urology|April 3, 2013
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trialPaolo Gontero, Marco Oderda, Anja Mehnert, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
European Radiology|March 15, 2022
mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imagingMarco Gatti, Riccardo Faletti, Francesco Gentile, et al.
Oncotarget|September 10, 2016
Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-upRossana Critelli, Francesca Fasanelli, Marco Oderda, et al.
Frontiers in Oncology|February 16, 2026
PSMA-guided management of recurrent post-prostatectomy patients: a sub-analysis of a prospective single-center studyGiuseppe Carlo Iorio, Cristiano Grossi, Valeria Chiofalo, et al.
Frontiers in Oncology|April 25, 2022
Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective StudyJunlong Zhuang, Yansheng Kan, Yuwen Wang, et al.
BJU International|May 27, 2020
Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 casesGiancarlo Marra, Junlong Zhuang, Mattia Beltrami, et al.
The Prostate|May 29, 2025
Role of Cell-Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2-ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active SurveillanceMarco Oderda, Giulia Orlando, Giorgio Calleris, et al.
European Urology Focus|May 17, 2020
Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?Giancarlo Marra, Giorgio Calleris, Paolo Alessio, et al.
Urologia|May 8, 2023
The impact of single-use digital flexible cystoscope for double J removal on hospital costs and work organization: A multicentric evaluationMarco Oderda, Antonio Amato, Jean de la Rosette, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Comparative Performance of <sup>68</sup>Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical ProstatectomyGuido Rovera, Serena Grimaldi, Marco Oderda, et al.
The Journal of Urology|April 3, 2013
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trialPaolo Gontero, Marco Oderda, Anja Mehnert, et al.
Pageof 18